Renal ablative therapy: Radiofrequency ablation and cryoablation

Journal of Surgical Oncology

Volumn 100, Issue 8, 2009, Pages 639-644

  Raman, Jay D ^a   Hall, David W ^a   Cadeddu, Jeffrey A ^b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cryoablation; Kidney; Nephron sparing surgery; Radiofrequency ablation (RFA); Renal cell carcinoma (RCC); Thermal ablation

Indexed keywords

BLOOD CLOTTING DISORDER; CANCER SURVIVAL; CELL DEATH; CLINICAL FEATURE; CRYOABLATION; ELECTRIC CURRENT; GLOMERULUS FILTRATION RATE; HEALTH STATUS; HEMATOMA; HEMATURIA; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; KIDNEY CARCINOMA; KIDNEY FUNCTION; KIDNEY TUMOR; LIFE EXPECTANCY; LIVER INJURY; MEMBRANE DAMAGE; MORBIDITY; PANCREAS INJURY; PRIORITY JOURNAL; PROTEIN DENATURATION; RADIOFREQUENCY ABLATION; RENAL PROTECTION; RENAL TUMOR ABLATION; REVIEW; SURGICAL TECHNIQUE; THERMAL INJURY; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME;

CATHETER ABLATION; CRYOSURGERY; HUMANS; KIDNEY NEOPLASMS;

EID: 73449128676     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21194     Document Type: Review

References (52)

1. Chow WH, Devesa SS, Warren JL, et al.: Rising incidence of renal cell cancer in the United States. JAMA 1999;281:1628-1631.
2. Hock LM, Lynch J, Balaji KC: Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: An analysis of surveillance, epidemiology and end results program data. J Urol 2002;167:57-60.
3. Hollingsworth JM, Miller DC, Daignault S, et al.: Rising incidence of small renal masses: A need to reassess treatment effect. J Natl Cancer Inst 2006;98:1331-1334.
4. Bosniak MA, Birnbaum BA, Krinsky GA, et al.: Small renal parenchymal neoplasms: Further observations on growth. Radiology 1995;197:589-597.
5. Rendon RA, Stanietzky N, Panzarella T, et al.: The natural history of small renal masses. J Urol 2000;164:1143-1147.
6. Uzzo RG, Novick AC: Nephron sparing surgery for renal tumors: Indications, techniques and outcomes. J Urol 2001;166: 6-18.
7. Fergany AF, Hafez KS, Novick AC: Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 2000;163:442-445.
8. Gill IS, Kavoussi LR, Lane BR, et al.: Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 2007;178:41-46.
9. Gill IS, Desai MM, Kaouk JH, et al.: Laparoscopic partial nephrectomy for renal tumor: Duplicating open surgical techniques. J Urol 2002;167:469-477, discussion 475-476.
10. Aron M, Gill IS: Renal tumor ablation. Curr Opin Urol 2005;15: 298-305.
11. Kwan KG, Matsumoto ED: Radiofrequency ablation and cryoablation of renal tumours. Curr Oncol 2007;14:34-38.
12. Lehman DS, Landman J: Kidney cancer ablative therapy: Indications and patient selection. Curr Urol Rep 2008;9:34-43.
13. Lehman DS, Landman J: Cryoablation and radiofrequency for kidney tumor. Curr Urol Rep 2008;9:128-134.
14. Watkin NA, Morris SB, Rivens IH, et al.: High-intensity focused ultrasound ablation of the kidney in a large animal model. J Endourol 1997;11:191-196.
15. Lotfi MA, McCue P, Gomella LG: Laparoscopic interstitial contact laser ablation of renal lesions: An experimental model. J Endourol 1994;8:153-156.
16. Yoshimura K, Okubo K, Ichioka K, et al.: Laparoscopic partial nephrectomy with a microwave tissue coagulator for small renal tumor. J Urol 2001;165:1893-1896.
17. Amersi FF, McElrath-Garza A, Ahmad A, et al.: Long-term survival after radiofrequency ablation of complex unresectable liver tumors. Arch Surg 2006;141:581-587, discussion 587-588.
18. Soong M, Jupiter J, Rosenthal D: Radiofrequency ablation of osteoid osteoma in the upper extremity. J Hand Surg [Am] 2006; 31:279-283.
19. Susini T, Nori J, Olivieri S, et al.: Radiofrequency ablation for minimally invasive treatment of breast carcinoma. A pilot study in elderly inoperable patients. Gynecol Oncol 2007;104: 304-310.
20. Park S, Anderson JK, Matsumoto ED, et al.: Radiofrequency ablation of renal tumors: Intermediate-term results. J Endourol 2006;20:569-573.
21. Zlotta AR, Wildschutz T, Raviv G, et al.: Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: Ex vivo and in vivo experience. J Endourol 1997;11:251-258.
22. Johnson DB, Cadeddu JA: Radiofrequency interstitial tumor ablation: Dry electrode. J Endourol 2003;17:557-562.
23. Hsu TH, Fidler ME, Gill IS: Radiofrequency ablation of the kidney: Acute and chronic histology in porcine model. Urology 2000;56:872-875.
24. Goldberg SN, Gazelle GS, Mueller PR: Thermal ablation therapy for focal malignancy: A unified approach to underlying principles, techniques, and diagnostic imaging guidance. Am J Roentgenol 2000;174:323-331.
25. Leveillee RJ, Hoey MF: Radiofrequency interstitial tissue ablation: Wet electrode. J Endourol 2003;17:563-577.
26. Margulis V, Matsumoto ED, Lindberg G, et al.: Acute histologic effects of temperature-based radiofrequency ablation on renal tumor pathologic interpretation. Urology 2004;64:660-663.
27. Gupta A, Raman JD, Leveillee RJ, et al.: General anesthesia and contrast enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: Multi-institutional intermediate term results. J Endourol (submitted).
28. Peralta AH, Goldber SN: Review of radiofrequency ablation for renal cell carcinoma. Clin Cancer Res 2004;10:6328S-6334S.
29. Gervais DA, McGovern FJ, Arellano RS, et al.: Radiofrequency ablation of renal cell carcinoma: Part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. Am J Roentgenol 2005;185:64-71.
30. Zagoria RJ, Traver MA, Werle DM, et al.: Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. Am J Roentgenol 2007;189:429-436.
31. Levinson AW, Su LM, Agarwal D, et al.: Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol 2008;180:499-504, discussion 504.
32. Uchida M, Imaide Y, Sugimoto K, et al.: Percutaneous cryosurgery for renal tumours. Br J Urol 1995;75:132-136, discussion 136-137.
33. Gill IS, Novick AC, Soble JJ, et al.: Laparoscopic renal cryoablation: Initial clinical series. Urology 1998;52:543-551.
34. Hoffmann NE, Bischof JC: The cryobiology of cryosurgical injury. Urology 2002;60:40-49.
35. Baust JG, Gage AA: The molecular basis of cryosurgery. BJU Int 2005;95:1187-1191.
36. Shingleton WB, Sewell PE Jr: Percutaneous renal tumor cryoablation with magnetic resonance imaging guidance. J Urol 2001; 165:773-776.
37. Campbell SC, Krishnamurthi V, Chow G, et al.: Renal cryosurgery: Experimental evaluation of treatment parameters. Urology 1998;52:29-33, discussion 33-24.
38. Cestari A, Guazzoni G, dell'Acqua V, et al.: Laparoscopic cryoablation of solid renal masses: Intermediate term followup. J Urol 2004;172:1267-1270.
39. Gill IS, Remer EM, Hasan WA, et al.: Renal cryoablation: Outcome at 3 years. J Urol 2005;173:1903-1907.
40. Lawatsch EJ, Langenstroer P, Byrd GF, et al.: Intermediate results of laparoscopic cryoablation in 59 patients at the Medical College of Wisconsin. J Urol 2006;175:1225-1229, discussion 1229.
41. Weld KJ, Figenshau RS, Venkatesh R, et al.: Laparoscopic cryoablation for small renal masses: Three-year follow-up. Urology 2007;69:448-451.
42. Aron M, Kamoi K, Haber G-P, et al.: Laparoscopic renal cryoablation: Long-term oncologic outcomes with minimum 5-year follow-up. J Urol 2008;179:209-210.
43. Johnson DB, Solomon SB, Su LM, et al.: Defining the complications of cryoablation and radio frequency ablation of small renal tumors: A multi-institutional review. J Urol 2004;172: 874-877.
44. Lucas SM, Stern JM, Adibi M, et al.: Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 2008;179:75-79, discussion 79-80.
45. Raman JD, Thomas J, Lucas SM, et al.: Radiofrequency ablation for T1a tumors in a solitary kidney: Promising intermediate oncologic and renal function outcomes. Can J Urol 2008;15: 3980-3985.
46. Matsumoto ED, Watumull L, Johnson DB, et al.: The radiographic evolution of radio frequency ablated renal tumors. J Urol 2004;172:45-48.
47. Park S, Strup SE, Saboorian H, et al.: No evidence of disease after radiofrequency ablation in delayed nephrectomy specimens. Urology 2006;68:964-967.
48. Roarke MC, Collins JM, Nguyen BD: Indolent enterococcal abscess mimicking recurrent renal cell carcinoma on MR imaging and PET/CT after radiofrequency ablation. J Vasc Interv Radiol 2006;17:1851-1854.
49. Marcovich R, Aldana JP, Morgenstern N, et al.: Optimal lesion assessment following acute radio frequency ablation of porcine kidney: Cellular viability or histopathology? J Urol 2003;170: 1370-1374.
50. Anderson JK, Baker M, Jaffers O, et al.: Time course of nicotinamide adenine dinucleotide diaphorase staining after renal radiofrequency ablation influences viability assessment. J Endourol 2007;21:223-227.
51. Finelli A, Rewcastle JC, Jewett MA: Cryotherapy and radiofrequency ablation: Pathophysiologic basis and laboratory studies. Curr Opin Urol 2003;13:187-191.
52. Raman JD, Stern JM, Zeltser I, et al.: Absence of viable renal carcinoma in biopsies performed more than 1 year following radio frequency ablation confirms reliability of axial imaging. J Urol 2008;179:2142-2145.